Background: In Cameroon, studies on the prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae (E-ESBLs) and carbapenemase-producing Enterobacteriaceae (CPE) among HIV infected individuals has not been investigated despite the progressively risen prevalence of HIV infection. The present study is intended determinate the magnitude of ESBL-E and CPE carriage among HIV-infected individuals. Methods: Accordingly, 152 urine, 29 stool, 8 blood, 105 vaginal exudates and 14 wound swab sample were collected from 204 HIV negative and 104 HIV positive patients attending the Regional Hospital of Bafoussam-Cameroon from September 2016 to June 2017. From these specimen, Enterobacteriaceae were isolated based on their morphological features, Gram staining and biochemical characteristics using API 20E galleries (Biomerieux, France). For each HIV infected patient, the CD4 lymphocytes were measured using cytometric technique. The antimicrobial susceptibility was determined by Kirby-Bauer disc diffusion test against 11 antibiotics from β-lactam class. ESBL and CP in suspected strains was confirmed by double disk synergy test and combination disk test.Results: The prevalence of Enterobacteriaceae infection among HIV positive patients was 46.15% versus 27.47% among HIV-negative ones (P=0.0014). Among HIV positive patients, urine (47.91%), vaginal exudates (31.25%) and blood (4.16%) specimens were mostly colonialized and Escherichia coli (37.5%) the predominant species. The rate of Enterobacteraceae infection according to CD4 count range was 20.83%, 37.5%, 35.42% and 6.25% respectively for patients with CD4 T lymphocyte range up to 500, ]300-500], ]100-300] and < 100 cells/mm3. The overall resistance rates were 27.72 and 34.66% respectively among isolates from HIV negative and positive patients. The prevalence of ESBL, AmpC and carbapenemase producing Enterobacteriaceae infection was 16.34, 12.5, and 4.81% respectively among HIV infected patients versus 8.62, 8.65 and 0% among HIV uninfected patients (p = 0.0055). Conclusion: Our findings showed that HIV positive patients are significantly more affected by Enterobacteriaceae infection than negative ones and that the rate of these bacterial infection likely increases with decrease CD4 counts. The present study also indicates that HIV positive patients are more likely to be infected by highly resistant organisms and had the highest carriage rate of ESBL, AmpC and carbapenemase producing Enterobacteriaceae compared to uninfected individuals in Western-Cameroon.